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The ability to measure reliably the changes in the physical and biochemical environment after a brain injury is of great value in
the prevention, treatment, and understanding of the secondary injuries. Three categories of multimodal brain monitoring exist:
direct signals which are monitored invasively; variables which may be monitored noninvasively; and variables describing brain
pathophysiology which are not monitored directly but are calculated at the bedside by dedicated computer software. Intracranial
pressure (ICP) monitoring, either as stand-alone value or study of a dynamic trend, has become an important diagnostic tool in
the diagnosis and management of multiple neurological conditions. Attempts have been made to measure ICP non-invasively, but
this is not a clinical reality yet. There is contrasting evidence that monitoring of ICP is associated with better outcome, and further
RCTs based on management protocol are warranted. Computer bedside calculation of “secondary parameters” has shown to be
potentially helpful, particularly in helping to optimize “CPP-guided therapy.” In this paper we describe the most popular invasive
andnon invasivemonitoringmodalities, with great attention to their clinical interpretation based on the current published evidence.
1. Introduction
Brain injury occurs either at the time of a direct insult or
subsequently due to changes in the physical and biochemical
environment. The ability to measure these changes reliably
is of paramount importance in order to tailor the treatment
to each individual patient and therefore prevent the onset of
secondary brain injury.
Multimodal brain monitoring can be grouped into three
categories:
(1) direct signals which are monitored invasively (e.g.,
intracranial pressure (ICP), tissue oxygenation,
microdialysis, parenchymal blood flow, etc.);
(2) variables which may be monitored noninvasively
(e.g., transcranial Doppler (TCD) or near infrared
spectroscopy (NIRS));
(3) variables describing brain pathophysiology which
are not monitored directly but are calculated at
the bedside by dedicated computer software. The
simplest example is the cerebral perfusion pressure
(CPP), which is the difference between the mean
arterial blood pressure (MAP) and the ICP (CPP =
MAP-ICP), and therefore it is a calculated variable.
More sophisticated examples include various indices
of vascular reactivity or cerebral autoregulation [1],
brain compensatory reserve [2], vascular resistances,
and brain compartmental compliances [3].
2. Intracranial Pressure (ICP)
Even though since the end of the 19th century the spinal CSF
pressure was used as indirect measure of ICP, the first reports
of the use of continuous intracranial pressure monitoring via
ventricular catheter were by Guillaume and Janny in 1951 [4]
and later by Lundberg in 1960 [5].With time, ICPmonitoring
has become an important component in the diagnosis and
management of multiple neurological conditions, such as
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Figure 1: Case of a head injury patient with a highly unstable ICP,
due to “plateau” waves. Details are in the text. ICP: intracranial
pressure. ABP: arterial blood pressure. CPP: cerebral perfusion
pressure.
head injury, hydrocephalus, subarachnoid haemorrhage, and
intracranial haematoma.
The particular anatomy of the brain, which is enclosed
and protected by a rigid skull, creates a unique pressure-
volume relationship compared to the rest of the human
body, as already described by Monroe and Kelly more than
200 years ago. In normal circumstances the ICP is kept
in its normal range, maintaining the relationship between
the cerebrospinal fluid (CSF), the intracerebral blood, and
brain tissue constant. In current clinical practice the ICP
is measured invasively using an intracranial (ventricular,
parenchymal, subdural, or extradural) catheter connected to
or integrated with a pressure transducer.
The interpretation of ICP using the single “number,”
either at one moment in time or the average over a period
of time (e.g., daily ICP), although useful, can often be
misleading. Figure 1 demonstrates the case of a head injury
patient with a highly unstable ICP, due to “plateau” waves.
It has a dynamic trend, ranging from 10 to above 55mmHg,
and any increase in ICP follows a decrease in CPP down to
40mmHg, during which secondary “brain insults” happen.
Such high ICP dynamics is not always well represented
by its average value and only continuous trending, with a
good representation of monitoring values, can reveal such a
hyperdynamic state.
The single value has a good potential to support sta-
tistical studies. In the study from 1996, the distribution of
mean ICP in different outcome groups reveals that those
who died have much greater mean ICP than survivors
[6]. Interestingly in survivors outcome groups there is no
difference between averaged ICP between favourable and
unfavourable outcomes. Mean ICP may be also used to
establish general threshold between normal and elevated ICP
(Figure 2). Undoubtedly, it is between 20 and 30mmHg,
where mortality rate starts to increase with ICP [7].
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Figure 2: Correlation between mortality rate and ICP. General
threshold between normal and elevated ICP between 20 and
30mmHg. ICP: intracranial pressure.
There is also evidence that thresholds may be found and
traced in time for individual cases [8]. Index of cerebrospinal
compensatory reserve, plotted against ICP, can show “sat-
uration,” associated with exhausted reserve above a certain
pressure. Above this level, any further rise of intracerebral
volumemay lead to refractory intracranial hypertension.This
phenomenon is undoubtedly fatal. Rise in ICP may be fast. It
is associated with decrease in CPP and cerebral ischaemia.
A recent RCT conducted by Chesnut and colleagues
demonstrated that for patients with severe brain injury care
that focused on maintaining monitored ICP at 20mmHg
or less was not shown to be superior to care based on
imaging and clinical examination [9]. However a “normal”
ICP should not be considered only in light of a particular
cut-off value, because waveform analysis of the ICP is also
important. ICP waveform analysis can provide information
on the state of cerebrovascular reactivity (PRx) and can be
used to estimate optimal cerebral perfusion pressure levels for
individual patients as described later in this paper [10].
3. Pressure Reactivity Index (PRx)
Cortical cerebral blood flow (CBF) can be monitored with
laser Doppler flowmetry, and CBF plotted against CPP shows
the autoregulatory curve, called Lassen’s curve, with clear
lower limit of autoregulation (LLA) (Figure 3). However
while this is illustrative of the principle, in clinical practice an
indicator able to predict the autoregulatory reserve is needed,
in order to demonstrate how far the patient is from the LLA.
A number of useful secondary indices are available for
this purpose. One of these is the pressure reactivity index
(PRx) [8]. It is calculated from slow fluctuation of the arterial
blood pressure (ABP) of a period between 20 seconds and
3 minutes. The response of the ICP may be passive when
the vascular bed is not reactive. PRx, calculated as moving
correlation coefficient between ABP and ICP with the pulse
wave filtered out, is positive. With an active vascular bed, a
rise in ABP produces vasoconstriction and a decrease in ICP.
A decrease in ABP produces vasodilatation and an increase
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Figure 3: (a) Cortical cerebral blood flow (CBF) can be monitored with laser Doppler flowmetry, and CBF plotted against CPP shows the
autoregulatory curve, called Lassen’s curve, with clear lower limit of autoregulation (LLA). ICP: intracranial pressure. ABP: arterial blood
pressure. CPP: cerebral perfusion pressure. LDF: laser Doppler flowmetry. (b) Lassen’s curve. CPP: cerebral perfusion pressure. LDF: laser
Doppler flowmetry.
Figure 4: Example of multiple days monitoring of PRx along with
ICP, ABP, and CPP where a patient attained good outcome after
severe head injury. Image extrapolated from ICM+ software. ICP:
intracranial pressure. ABP: arterial blood pressure. CPP: cerebral
perfusion pressure. PRx: pressure reactivity index.
in ICP.Therefore, normally positive PRx starts to be negative,
indicating negative correlation between slow changes in ABP
and ICP.
PRx is a “moving index,” able to be calculated contin-
uously, forming a new variable. Figure 4 shows an example
of multiple days monitoring of PRx along with ICP, ABP,
and CPP where a patient attained good outcome after severe
head injury. It is possible to see that pressure reactivity may
fluctuate in time after TBI. In cases of refractory intracranial
hypertension, PRx sometimes deteriorates before the onset
of intracranial hypertension. Figure 5 shows an increase in
ICP above 20 and then above 80mmHg. PRx in this case
deteriorates almost half of a day before.
PRx gives similar results to ICP when plotted against
mortality rate, but with even steeper threshold.Mortality rate,
expressed as a function of CPP, shows distinctive “U shape”
curve (Figure 6). It indicates that themajority of patients who
die have either too low or too high CPP. Whether what is
“inadequate” CPP, is still a cause of debate. But if in the same
cohort of patients PRx versus CPP is plotted, a similar “U
shape” can be traced.
An algorithm (Figure 7) was proposed by Steiner in
order to trace the PRx/CPP curve [11]. The minimum of the
curve was named “optimal CPP.” Steiner, using retrospective
data, proved that greater distance between “optimal” and
current CPP associates with worse outcome following TBI.
A randomized trial is required to see whether “optimization”
of CPP may improve outcome after TBI.
4. Brain Tissue Oxygenation (PbtO2)
The second most popular brain monitoring modality is brain
tissue oxygenation (PbtO
2
). In order to monitor it, a thin
electrode, able to detect oxygen content, is introduced into
the brain parenchyma, allowing only a very small sampling
area, just above a cubic millimetre.
Long-term trend (several days) of PbtO
2
recorded along
ICP, ABP, and CPP frequently fails to show any association
between the modalities. However if selected time periods
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Figure 5: Increase in ICP above 20 and then above 80mmHg. PRx in this case deteriorates almost half of a day before. ICP: intracranial
pressure. ABP: arterial blood pressure. CPP: cerebral perfusion pressure. PRx: pressure reactivity index.
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Figure 6: Mortality rate, expressed as a function of CPP, shows
distinctive “U shape” curve. CPP: cerebral perfusion pressure.
with more dynamical changes in PbtO
2
are used, the positive
correlation between CPP and PbtO
2
becomes more apparent
[12]. This perhaps indicates that by increasing CPP it is
possible to improve brain tissue oxygenation, and this is
interpreted in such a way by many neuroscientists.
The main problem in PbtO
2
is that it may change
dramatically, regarding different regions of the brain. Work
conducted in Cambridge by Gupta and colleagues shows
good correlation between PbtO
2
and jugular bulb blood
oxygenation only in areas without focal injury. In areas with
focal injury, the correlation is absent. This has also been
confirmed in other studies [13].
Ingenious idea was proposed by Jaeger et al. [14] to use
PbtO
2
to calculate an oxygen reactivity index; in a similar
way PRx is calculated, by correlating changes in PbtO
2
and
CPP from the time window of about 1 hour. Positive ORX
was supposed to indicate the situation when PbtO
2
may be
improved by increasing CPP, and ORX around zero when no
further oxygenation improvement would be achieved with
increasing CPP. At least, in the range of positive ORX, this
index should be associated to PRx, but unfortunately this
cannot be confirmed by other studies [15].
5. Near Infrared Spectroscopy (NIRS) and
Transcranial Doppler (TCD)
Near infrared spectroscopy (NIRS) is a noninvasive modal-
ity to monitor changes in oxygen saturation in the brain.
Compared to the previously described modality, it covers
several cubic centimetres when applied to a central lobe.
The theoretical basis lies on the fact that in the context
of intracranial hypertension, slow waves in ICP have been
found, which occur in 0.3 to 2.0 cycles per minute. Several
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Figure 7: An algorithm to trace the PRx/CPP curve. CPP: cerebral
perfusion pressure. PRx: pressure reactivity index.
studies demonstrated a relationship between those slow
waves with ICP and cerebral oxygenation [16].
Figure 8 shows multimodal monitoring during a plateau
wave of ICP, demonstrating a decrease in CPP, PbtO
2
, blood
flow velocity (which was assessed with TCD), and HbO
2
during the curve, resulting in an ischaemic insult.
NIRS can record relative changes in the concentration
of deoxygenated (Hb) and oxygenated (HbO
2
) haemoglobin
[16]. Normally, fluctuations in Hb and HbO
2
are normally
negatively correlated with each other, but in the presence of
the vasogenic waves of ICP they would change in the same
directions [16].
Experiments on arterial hypotension in piglets conducted
at the John’s Hopkins universty, revealed LLA, using laser
Doppler and Somanetics cerebral oxygenation index [17]. In
the same institution similarly good association betweenNIRS
andTCD-divided indiceswas found in autoregulation indices
derived with TCD and NIRS [18].
Positive association between themeasurements—divided
TOX index and TCD-assessed autoregulation—was docu-
mented in a group of patients with sepsis in the study from
Basel [19].
6. Conclusion
In conclusion ICP still remains the most important modality
of brain monitoring. However there is contrasting evidence
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Figure 8: Multimodal monitoring during a plateau wave of ICP,
demonstrating a decrease in CPP, PbtO
2
, blood flow velocity
(which was assessed with TCD), and HbO
2
during the curve,
resulting in an ischaemic insult. ICP: intracranial pressure. NIRS
THI: near infrared spectroscopy, tissue haemoglobin index. CPP:
cerebral perfusion pressure. TCD FV: Trans Cranial Doppler Flow
Velocity. PtiO2: brain tissue oxygenation. NIRS TOI: near infrared
spectroscopy, tissue oxygenation index.
thatmonitoring of ICP is associated with better outcome, and
further prospective, multicentre, randomized trials, based on
management protocol, are needed. Nobody can expect the
outcome to improve by monitoring only, but it should be a
monitoring-management combo instead.
PbtO
2
, apart from the initial enthusiasm, is not certain.
The most significant disadvantage is that we are a hostage of
catheter placement area.
“Optimal CPP” seems to be an important and promising
idea, but yet to be confirmed by anRCT. Itmay be understood
as a consensus betweenCPP-oriented therapy, where the CPP
should be kept high, and Lund concept, where CPP can be
kept low in order to reduce transcapillary water leak, lower
oedema, and ICP. “Optimal CPP” says: not too low, not too
high, just maintained to the needs of individual.
Finally, computer bedside calculation of “secondary
parameters”may be helpful—again should be subject of more
prospective clinical studies. Do we need a hole?Maybe, in the
future, not always. Many laboratories work on noninvasive
ICP, based on TCD and arterial pressure analyses. We hope
that noninvasive ICP will become feasible in the future.
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